Robot-assisted prostatectomy for pT3. Oncological and functional outcomes

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In 2020, prostate cancer (PCa) ranked third in the structure of the most significant oncological diseases. In the Russian Federation, in terms of the frequency of detection among men, prostate cancer is second only to tumors of the upper respiratory tract and lungs, accounting for 14.9%. Radical prostatectomy (RP) in various modifications is still the most common treatment for localized prostate cancer, despite the existence of alternatives such as active surveillance, hormonal and radiation therapy, cryoablation, and others. And the technological pinnacle of the surgical treatment of prostate cancer at the moment is robot-assisted prostatectomy, the widespread use of which was marked by the publication of J. Binder back in 2002. This technology combined the advantages of minimally invasive laparoscopic RP with improved surgeon ergonomics and technical ease of vesicourethral anastomosis reconstruction and has now become the preferred minimally invasive approach. This article will consider the use of a robot-assisted technique in the stage of T3 prostate cancer.

Full Text

Restricted Access

About the authors

R. М. Medvedev

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: kb80@yandex.ru

resident at the Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko

Russian Federation, Moscow; Moscow

K. B. Kolontarev

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: kb80@yandex.ru

Ph.D., MD, Professor at the Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko, Deputy Chief

Russian Federation, Moscow; Moscow

А. А. Govorov

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: dr.govorov@gmail.com
ORCID iD: 0000-0003-3299-0574

Ph.D., MD, professor of RAS, professor at the Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko, urologist

Russian Federation, Moscow; Moscow

К. S. Skrupskii

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: kb80@yandex.ru

urologist, Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko

Russian Federation, Moscow; Moscow

А. О. Vasiliev

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: kb80@yandex.ru

Ph.D., assistant at the Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko, urologist

Russian Federation, Moscow; Moscow

V. V. Dyakov

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: kb80@yandex.ru

Ph.D., urologist, Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko

Russian Federation, Moscow; Moscow

А. А. Kotelnikova

FGBOU VO “Russian University of Medicine”

Email: kb80@yandex.ru

resident at the Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko

Russian Federation, Moscow

А. А. Vitoslavsky

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Email: kb80@yandex.ru

resident at the Department of Urology Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko

Russian Federation, Moscow; Moscow

D. Yu. Pushkar

FGBOU VO “Russian University of Medicine”; Moscow Urological Center of S.P. Botkin City Clinical Hospital

Author for correspondence.
Email: pushkardm@mail.ru
ORCID iD: 0000-0002-6096-5723

Academician of RAS, Ph.D., MD, Professor, Head of the Department of Urology Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko, Chief, Chief urologist of the Ministry of Health of Russia

Russian Federation, Moscow; Moscow

References

  1. Culp M.B., Soerjomataram I., Efstathiou J.A., Bray F., Jemal A. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol. 2020;77(1):38–52. Doi: 101016/j. eururo.2019.08.005.
  2. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России; 2019.
  3. Mottet N., Bellmunt J., Bolla M., Briers E., Cumberbatch M.G., De Santis M., Fossati N., Gross T., Henry A.M., Joniau S., Lam T.B., Mason M.D., Matveev V.B., Moldovan P.C., van den Bergh R.C.N., Van den Broeck T., van der Poel H.G., van der Kwast T.H., Rouvière O., Schoots I.G., Wiegel T., Cornford P. EAU-ESTROSIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618–629. doi: 10.1016/j.eururo.2016.08.003.
  4. Binder J., et al. [Robot-assisted laparoscopy in urology. Radical prostatectomy and reconstructive retroperitoneal interventions]. Urologe A, 2002;41:144. PMID: 11993092.doi: 10.1007/s00120-002-0178-2.
  5. Tewari A., Srivasatava A., Menon M. et al. A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int 2003;92(3):205–210. doi: 10.1046/j.1464-410x.2003.04311.x.
  6. Yaxley J.W., et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet. 2016;388:1057. PMID: 27474375. doi: 10.1016/S0140-6736(16)30592-X
  7. Ficarra Vincenzo, Novara Giacomo, Dasgupta Prokar. Robot-assisted versus open radical prostatectomy: the day after. BJU International. 2017. doi: 10.1111/bju.13891
  8. Tang K., Jiang K., Chen H. et al. Robotic vs. Retropubic radical prostatectomy in prostate cancer: A systematic review and an metaanalysis update. Oncotarget 2017;8(19):32237–3257. Doi: 10.18632/ oncotarget.13332.
  9. Gandaglia G., Sammon J.D., Chang S.L. et al. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol 2014;32(14):1419–1426. Doi: 10.1200/ JCO.2013.53.5096.
  10. Patel Vipul. Robotic Radical Prostatectomy: The Outcomes of 450 Cases. The Journal of Urology. 2005;173(4):188. doi: 10.1016/s0022-5347(18)35921-4
  11. Suardi N., Ficarra V., Willemsen P., et al. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years. Urology. 2012;79:133–138.
  12. Hu J.C., et al. Comparative Effectiveness of Robot-assisted Versus Open Radical Prostatectomy Cancer Control. Eur Urol. 2014;66(4):666–672. http://dx.doi.org/10.1016/j.eururo.2014.02.015
  13. Raheem A.A., Kim D.K., Santok G.D., Alabdulaali I., Chung B.H., Choi Y.D., Rha K.H. Stratified analysis of 800 Asian patients after robot-assisted radical prostatectomy with a median 64 months of follow up. Int J Urol. 2016;23:765–774.
  14. Billia M., Elhage O., Challacombe B., Cahill D., Popert R., Holmes K., Kirby R.S., Dasgupta P. Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years. World J Urol. 2013;32(2):413–418.
  15. Lee D., Choi S.-K., Park J., Shim M., Kim A., Lee S., Song C., Ahn H. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer. Korean J Urol. 2015;56(8):572.
  16. Koo K.C., Tuliao P., Yoon Y.E., Chung B.H., Hong S.J., Yang S.C., Rha K.H. Robot-assisted radical prostatectomy in the Korean population: a 5-year propensity-score matched comparative analysis versus open radical prostatectomy. Int J Urol. 2014;21(8):781–785.
  17. Wang Lei, Wang Baojun, Ai Qing, Zhang Yu, Lv Xiangjun, Li Hongzhao, Ma Xin, Zhang Xu. Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis. International Urology and Nephrology. 2017;49(6):995–1005. doi: 10.1007/s11255-017-1552-8.
  18. Porpiglia F., et al. Five-year Outcomes for a Prospective Randomised Controlled Trial Comparing Laparoscopic and Robot-assisted Radical Prostatectomy. Eur Urol Focus. 2016. http://dx.doi.org/10.1016/j.euf.2016.11.007
  19. Yaxley John W., Coughlin Geoffrey D., Chambers Suzanne K., Occhipinti Stefano, Samaratunga Hema, Zajdlewicz Leah, Dunglison Nigel, Carter Rob, Williams Scott, Payton Diane J., Perry-Keene Joanna, Lavin Martin F., Gardiner Robert A. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet. 2016;S014067361630592X-. doi: 10.1016/S0140-6736(16)30592-X
  20. Herlemann A., et al. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy. Eur Urol. 2018;73(2):215–223.
  21. Wallerstedt A., Quality of Life After Open Radical Prostatectomy Compared with Robot-assisted Radical Prostatectomy. Eur Urol Focus. 2019;5(3):389–398. https://doi.org/10.1016/j.euf.2017.12.010
  22. Cao Lan, Yang Zhenyu, Qi Lin, Chen Minfeng. Robot-assisted and laparoscopic vs open radical prostatectomy in clinically localized prostate cancer. Medicine. 2019;98(22):e15770. doi: 10.1097/md.0000000000015770
  23. Nyberg M., et al. Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial. Eur Urol Oncol. 2018;1(5):353–360. https://doi.org/10.1016/j.euo.2018.04.012
  24. Ali Abdel Raheem, Ayman Hagras, Ahmed Ghaith, Mohamed J. Alenzi, Ahmed Elghiaty, Tarek Gameel, Ibrahim Alowidah, Won S. Ham, Young D. Choi, Abdel H. El-Bahnasy, Adel Omar, Mohamed El-Bendary, Koon H. RHA Retzius-sparing robot-assisted radical prostatectomy versus open retropubic radical prostatectomy: a prospective comparative study with 19-month follow-up. Minerva Urol Nefrol. 2020;72(5):586–594. doi: 10.23736/S0393-2249.20.03830-8
  25. Deng W., Liu X., Liu W., Zhang C., Zhou X., Chen L., Guo J., Wang G., Fu B. Functional and Oncological Outcomes Following Robot-Assisted and Laparoscopic Radical Prostatectomy for Localized Prostate Cancer With a Large Prostate Volume: A Retrospective Analysis With Minimum 2-Year Follow-Ups. Front. Oncol. 2021;11:714680. doi: 10.3389/fonc.2021.714680.
  26. Dorit E. Zilberman, Yasmin Abu-Ghanem, Gil Raviv, Barak Rosenzweig, Eddie Fridman, Orith Portnoy, Zohar A Dotan Oncologic Outcomes Following Robot-Assisted Radical Prostatectomy for Clinical T3 Prostate Disease Isr Med Assoc J. 2021;23(2):111–115.
  27. Ching-Wei Yang, Hsiao-Hsien Wang, Mohamed Fayez Hassouna, Manish Chand, William J.S. Huang, Hsiao-Jen Chung. Prediction of a positive surgical margin and biochemical recurrence after robot-assisted radical prostatectomy. Scientific Reports, 2021;11(1):14329. doi: 10.1038/s41598-021-93860-y.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies